NEW YORK, August 14, 2017 /PRNewswire/ --
If you want a Stock Review on A, ALR, Q, or TMO then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. Focus is on the Medical Laboratories space, which includes independent commercial enterprises that provide information to health care professionals about the severity, onset, and reason of patients' physical ailments. Pre-market today, DailyStockTracker.com monitors the previous performances of the following companies: Agilent Technologies Inc. (NYSE: A), Alere Inc. (NYSE: ALR), Quintiles IMS Holdings Inc. (NYSE: Q), and Thermo Fisher Scientific Inc. (NYSE: TMO). These free stocks reports are currently available on DailyStockTracker.com. Simply sign up for your complimentary member access at:
Santa Clara, California headquartered Agilent Technologies Inc.'s shares rose 1.30%, finishing last Friday's session at $59.33. A total volume of 1.51 million shares was traded. Over the previous three months and since the start of this year, the stock has advanced 5.64% and 30.22%, respectively. The Company's shares are trading above their 200-day moving average by 12.73%. Additionally, shares of Agilent Technologies, which provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide, have a Relative Strength Index (RSI) of 44.35.
On July 28th, 2017, Agilent Technologies announced that it will release Q3 FY17 financial results after the stock market closes on August 15th, 2017. The Company will host a live webcast of its investor conference call at 1:30 p.m. PST on that same day. The webcast may be accessed in listen-only mode on the Company's investor website. Your complete research report on A can be retrieved for free at:
On Friday, shares in Waltham, Massachusetts headquartered Alere Inc. ended the session 0.08% higher at $49.64. The stock recorded a trading volume of 731,000 shares. The Company's shares have gained 6.30% in the previous three months and 27.38% on an YTD basis. The stock is trading above its 200-day moving average by 14.02%. Moreover, shares of Alere have an RSI of 40.32.
On August 03rd, 2017, Alere announced its financial results for Q2 and six months ended June 30th, 2017. For Q2 2017, total revenue was $558 million; non-GAAP organic growth was -7.8%; GAAP loss from continuing operations was $(93) million; and non-GAAP adjusted EBITDA was $44 million. For the six months ended June 30th, 2017, revenue was $1.15 billion, and non-GAAP organic growth was -3.6%. A free report on ALR is just a click away at:
Durham, North Carolina headquartered Quintiles IMS Holdings Inc.'s stock climbed 1.53%, to close the day at $88.91. A total volume of 1.01 million shares was traded, which was above their three months average volume of 996,440 shares. The Company's shares have advanced 7.26% over the previous three months and 16.91% since the start of this year. The stock is trading 9.24% above its 200-day moving average. Additionally, shares of the Company, which provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and Asia/Pacific, have an RSI of 46.11.
On July 25th, 2017, Quintiles IMS Holdings announced the appointment of Colleen Goggins to its Board of Directors, effective that day. A senior executive at Johnson & Johnson (J&J) for more than three decades, Ms. Goggins retired in 2011 after serving ten years on J&J's Executive Committee and as the Worldwide Chairman of its Consumer Group. Under her leadership, the J&J global personal and healthcare portfolio grew to more than $16 billion in annual revenue.
On August 04th, 2017, research firm William Blair upgraded the Company's stock rating from 'Market Perform' to 'Outperform'. Sign up for your complimentary research report on Q at:
Thermo Fisher Scientific
Shares in Waltham, Massachusetts headquartered Thermo Fisher Scientific Inc. recorded a trading volume of 2.20 million shares, which was above their three months average volume of 1.36 million shares. The stock ended at $173.23, climbing 0.87% from the last trading session. The Company's shares have gained 1.00% over the previous three months and 22.77% on an YTD basis. The stock is trading above its 200-day moving average by 8.80%. Furthermore, shares of the Company have an RSI of 40.45.
On July 20th, 2017, research firm Cleveland Research upgraded the Company's stock rating from 'Neutral' to 'Buy'.
On August 10th, 2017, Thermo Fisher Scientific announced that it has priced an offering of $1.5 billion aggregate principal amount of the following notes: $750 million aggregate principal amount of its 3.200% senior notes due 2027, at an issue price of 99.263% of their principal amount; and $750 million aggregate principal amount of its 4.100% senior notes due 2047, at an issue price of 98.825% of their principal amount. The issuance of the notes is expected to close on August 14th, 2017. Register for free on DailyStockTracker.com and download the latest research report on TMO at:
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: (207)331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA